Home Privacy Archive Realtime Report

Stock Trading History of Rothman John F

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Rothman John F since year 2005. The trader's CIK number is 1238323. At the time of this reporting, Rothman John F is the VP of Clinical Development of Advaxis, Inc. (stock ticker symbol GXPT).

Stock purchases, sales, and option exercises reported by *Rothman John F* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-10-25	ADXS	Advaxis, Inc.	Purchase	61,043	.18	10,987
2007-02-23	ADXS	Advaxis, Inc.	Purchase	134,732	.16	21,557

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rothman John F (VP of Clinical Development of Advaxis, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.